Daprodustat

Description	GSK1278863 is a novel HIF-PHI, is a novel small molecule agent which has the ability to stimulate the HIF pathway and therefore, it is under investigation for treatment of anemia associated with chronic kidney disease. GSK1278863 is an investigative drug under investigation for treatment of anemia associated with chronic kidney disease.GSK1278863 is an orally administered small-molecule PHI, stabilizes HIF, which is known to modulate HIF-controlled gene products including EPO. GSK1278863 induced an effective EPO response and stimulated non-EPO mechanisms for erythropoiesis in anemic non-dialysis-dependent and dialysis-dependent patients with CKD. GSK1278863 is an orally-active small molecule agent that inhibits hypoxia-inducible factor (HIF) prolyl-4-hydroxylases (PHDs) that is currently in clinical development for the treatment of anemia associated with chronic kidney disease (CKD).
Pathways	Angiogenesis/Protein Tyrosine Kinase
Targets	HIF

Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.

For product details of different batches, please contact our Customer

Products are for research use only and not for human use. We do not sell to patients.